Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasms, Urinary Bladder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00011518
What this trial is testing

Bladder Cancer Case Control Study of Arsenic in Water

Who this might be right for
Bladder Cancer
National Institute of Environmental Health Sciences (NIEHS) 600
Testing effectiveness (Phase 2)Looking for participantsNCT05503797
What this trial is testing

Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Who this might be right for
Cancer Harboring BRAF AlterationsHGGLGG+1 more
Fore Biotherapeutics 254
Testing effectiveness (Phase 2)Looking for participantsNCT07647289
What this trial is testing

EV + Toripalimab vs GC as Neoadjuvant Therapy in Locally Advanced/High-Risk MIBC

Who this might be right for
Muscle-Invasive Bladder Cancer (MIBC)
Peking University Third Hospital 58
Not applicableLooking for participantsNCT06092450
What this trial is testing

Deep Learning Radiomics Model for Predicting Post-cystectomy Outcome in Muscle Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
First Affiliated Hospital of Chongqing Medical University 500
Large-scale testing (Phase 3)Study completedNCT00002990
What this trial is testing

Surgery and BCG in Treating Patients With Bladder Cancer

Who this might be right for
Bladder Cancer
European Organisation for Research and Treatment of Cancer - EORTC 1,288
Testing effectiveness (Phase 2)Active Not RecruitingNCT03978624
What this trial is testing

Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer

Who this might be right for
Bladder Cancer
UNC Lineberger Comprehensive Cancer Center 20
Not applicableStudy completedNCT03328988
What this trial is testing

QLB and Radical Cystectomy, Postoperative Pain

Who this might be right for
Postoperative PainChronic Pain Post-ProceduraalNausea and Vomiting, Postoperative
Tampere University Hospital 41
Large-scale testing (Phase 3)Ended earlyNCT02563561
What this trial is testing

Intravesical Apaziquone as a Surgical Adjuvant in Participant Undergoing Transurethral Resection Bladder Tumor (TURBT)

Who this might be right for
Bladder Cancer
Spectrum Pharmaceuticals, Inc 62
Testing effectiveness (Phase 2)Looking for participantsNCT07475403
What this trial is testing

Urinary Tumor DNA-Guided Systemic Immunotherapy for Unresectable Very-High-Risk Non-Muscle-Invasive Bladder Cancer

Who this might be right for
Bladder CancerLiquid BiopsyImmunotherapy
Tianjin Medical University Second Hospital 53
Not applicableStudy completedNCT01637935
What this trial is testing

Cohort Study of Pioglitazone and Bladder Cancer in Patients With Type II Diabetes

Who this might be right for
DiabetesBladder Cancer
Takeda 193,099
Not applicableActive Not RecruitingNCT06414317
What this trial is testing

An Education and Navigation Support Tool to Improve Participation in Care Coordination Among Patients With Locally Advanced, Metastatic and Unresectable Bladder Cancer and Their Caregivers

Who this might be right for
Locally Advanced Bladder CarcinomaMetastatic Bladder CarcinomaStage III Bladder Cancer AJCC v8+2 more
Roswell Park Cancer Institute 12
Large-scale testing (Phase 3)Looking for participantsNCT06510374
What this trial is testing

Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

Who this might be right for
Intermediate Risk Non-Muscle Invasive Bladder Cancer
Ferring Pharmaceuticals 454
Not applicableEnded earlyNCT00216814
What this trial is testing

Antiangiogenic Effects of BCG on Urinary Concentration of Angiogenic Factors

Who this might be right for
Bladder Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 220
Testing effectiveness (Phase 2)Ended earlyNCT01382706
What this trial is testing

Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder

Who this might be right for
Recurrent Bladder CancerStage III Bladder CancerStage IV Bladder Cancer+1 more
University of Southern California 15
Not applicableStudy completedNCT04617743
What this trial is testing

The Effect of Post-voiding Reisdual Urine on Non-muscle Invasive Bladder Cancer Recurrence and Progression

Who this might be right for
Bladder Cancer RecurrentNon-Invasive Bladder Urothelial Carcinoma
Istanbul Medeniyet University 500
Not applicableEnded earlyNCT01495676
What this trial is testing

A Phase II Trial Evaluating an Organ-conserving Strategy by Radiochemotherapy for Muscle-infiltrative Bladder Cancer

Who this might be right for
Infiltrating Bladder Urothelial Carcinoma
Institut du Cancer de Montpellier - Val d'Aurelle 69
Not applicableLooking for participantsNCT05739968
What this trial is testing

Impacts and Testing of the "Multi-domains Active-living Program" in Operable Non-Muscle Invasive Bladder Cancer Patients

Who this might be right for
Bladder CancerQuality of Life
National Taiwan University Hospital 120
Not applicableStudy completedNCT05082818
What this trial is testing

Outcome of Treating Bladder Cancer in Sohag University Hospital

Who this might be right for
Bladder Cancer
Sohag University 168
Early research (Phase 1)Study completedNCT00083213
What this trial is testing

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Cancer
Regeneron Pharmaceuticals 25
Not applicableStudy completedNCT05154084
What this trial is testing

RESECT: Improving Quality in TURBT Surgery.

Who this might be right for
Bladder Cancer
British Urology Researchers in Surgical Training 19,505
Next Page